Stock Screener App

Frei -

Installieren

14.38

1.77% 0.25

after-market

Handel nachbörslich: 14.38

Trevi Therapeutics Inc (TRVI)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Trevi Therapeutics Inc-Aktie (TRVI)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	1.41% 13.92	13.72	11.47	12.24	14.09
Operating Income/Loss	1.41% -13.92	-13.72	-11.47	-12.24	-14.09
Nonoperating Income/Loss	49.93% 2.099	1.40	1.119	0.844	0.814
Income/Loss From Continuing Operations Before Tax	4.10% -11.82	-12.32	-10.35	-11.40	-13.27
Income Tax Expense/Benefit	28.57% -0.015	-0.021	-0.011	0.016	-0.031
Income/Loss From Continuing Operations After Tax	4.06% -11.80	-12.30	-10.34	-11.41	-13.24
Net Income/Loss	4.06% -11.80	-12.30	-10.34	-11.41	-13.24
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	11.32% 145.10	130.35	117.61	1.3558	101.28
Diluted Average Shares	11.32% 145.10	130.35	117.61	1.3558	101.28
Basic Earnings Per Share	11.11% -0.08	-0.09	-0.09	-0.11	-0.13
Diluted Earnings Per Share	11.11% -0.08	-0.09	-0.09	-0.11	-0.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ROIV

$29.66

0.98%

BNTX

$92.25

0.12%

INSM

$108.87

2.48%

RPRX

$53.86

1.17%

ONC

$302.44

2.52%

RVMD

$154.89

2.20%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters